HK1084401A1 - Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals - Google Patents
Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammalsInfo
- Publication number
- HK1084401A1 HK1084401A1 HK06104586.6A HK06104586A HK1084401A1 HK 1084401 A1 HK1084401 A1 HK 1084401A1 HK 06104586 A HK06104586 A HK 06104586A HK 1084401 A1 HK1084401 A1 HK 1084401A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- erg4
- mutants
- mammals
- expression
- saccharomyces cerevisiae
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10242763A DE10242763A1 (de) | 2002-09-14 | 2002-09-14 | Verwendung von Saccharomyces cerevisiae erg4-Mutanten zur Expression von Glukosetransportern aus Säugetieren |
PCT/EP2003/009812 WO2004026907A2 (de) | 2002-09-14 | 2003-09-04 | Verwendung von saccharomyces cerevisiae erg4-mutanten zur expression von glukosetransportern aus säugetieren |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1084401A1 true HK1084401A1 (en) | 2006-07-28 |
Family
ID=31724774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06104586.6A HK1084401A1 (en) | 2002-09-14 | 2006-04-18 | Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1539958A2 (de) |
JP (1) | JP4520854B2 (de) |
KR (1) | KR101233998B1 (de) |
CN (1) | CN1694960B (de) |
AU (1) | AU2003264257B2 (de) |
BR (1) | BR0314115A (de) |
CA (1) | CA2498636C (de) |
DE (1) | DE10242763A1 (de) |
HK (1) | HK1084401A1 (de) |
IL (2) | IL167321A (de) |
MX (1) | MXPA05002816A (de) |
NO (1) | NO20051795L (de) |
RU (1) | RU2345136C2 (de) |
WO (1) | WO2004026907A2 (de) |
ZA (1) | ZA200501871B (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102899328A (zh) * | 2012-09-28 | 2013-01-30 | 南京农业大学 | 山羊葡萄糖转运载体4基因及其重组表达载体和应用 |
CN110408616B (zh) * | 2019-07-09 | 2021-06-15 | 中南民族大学 | GLUT4基因敲除的sgRNA、A549细胞系及其构建方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6303373B1 (en) * | 1999-06-09 | 2001-10-16 | Whitehead Institute For Biomedical Research | Method of measuring plasma membrane targeting of GLUT4 |
US5942398A (en) * | 1998-02-26 | 1999-08-24 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules encoding glutx and uses thereof |
DE10106718A1 (de) * | 2001-02-14 | 2002-09-05 | Aventis Pharma Gmbh | Hefestamm von Saccharomyces cerevisiae mit funktioneller Expression eines Glut-Transporters |
-
2002
- 2002-09-14 DE DE10242763A patent/DE10242763A1/de not_active Withdrawn
-
2003
- 2003-09-04 EP EP03797264A patent/EP1539958A2/de not_active Withdrawn
- 2003-09-04 RU RU2005110955/13A patent/RU2345136C2/ru not_active IP Right Cessation
- 2003-09-04 CN CN038251485A patent/CN1694960B/zh not_active Expired - Fee Related
- 2003-09-04 JP JP2004536979A patent/JP4520854B2/ja not_active Expired - Fee Related
- 2003-09-04 AU AU2003264257A patent/AU2003264257B2/en not_active Ceased
- 2003-09-04 BR BR0314115-2A patent/BR0314115A/pt not_active IP Right Cessation
- 2003-09-04 KR KR1020057004292A patent/KR101233998B1/ko not_active IP Right Cessation
- 2003-09-04 CA CA2498636A patent/CA2498636C/en not_active Expired - Fee Related
- 2003-09-04 WO PCT/EP2003/009812 patent/WO2004026907A2/de active Application Filing
- 2003-09-04 MX MXPA05002816A patent/MXPA05002816A/es active IP Right Grant
-
2005
- 2005-03-04 ZA ZA2005/01871A patent/ZA200501871B/en unknown
- 2005-03-08 IL IL167321A patent/IL167321A/en not_active IP Right Cessation
- 2005-04-12 NO NO20051795A patent/NO20051795L/no not_active Application Discontinuation
-
2006
- 2006-04-18 HK HK06104586.6A patent/HK1084401A1/xx not_active IP Right Cessation
-
2009
- 2009-03-16 IL IL197621A patent/IL197621A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2004026907A2 (de) | 2004-04-01 |
AU2003264257A1 (en) | 2004-04-08 |
RU2345136C2 (ru) | 2009-01-27 |
CA2498636A1 (en) | 2004-04-01 |
CA2498636C (en) | 2012-04-17 |
RU2005110955A (ru) | 2006-01-20 |
NO20051795L (no) | 2005-06-08 |
EP1539958A2 (de) | 2005-06-15 |
ZA200501871B (en) | 2005-10-26 |
KR101233998B1 (ko) | 2013-02-18 |
WO2004026907A3 (de) | 2004-11-11 |
CN1694960A (zh) | 2005-11-09 |
JP4520854B2 (ja) | 2010-08-11 |
AU2003264257B2 (en) | 2010-05-20 |
KR20050056206A (ko) | 2005-06-14 |
IL197621A0 (en) | 2011-08-01 |
BR0314115A (pt) | 2005-07-12 |
MXPA05002816A (es) | 2005-05-27 |
IL167321A (en) | 2013-11-28 |
DE10242763A1 (de) | 2004-03-18 |
JP2006517088A (ja) | 2006-07-20 |
IL197621A (en) | 2014-01-30 |
CN1694960B (zh) | 2010-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003225782A1 (en) | Fluoropolymer blends and multilayer articles | |
AU2003221377A1 (en) | Solid electrolytic capacitor | |
AU2003288230A1 (en) | Aircraft door arrangement | |
AU2003298911A1 (en) | Cyclosporins for the treatment of autoimmune diseases | |
AU2003282687A8 (en) | Glucose transport mutants for production of biomaterial | |
IL197621A0 (en) | Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals | |
AU2003215990A1 (en) | Saccharomyces cerevisiae mutant | |
SG104358A1 (en) | Double floor structure | |
EP1329533B8 (de) | Lasernitrieren von Aluminiumbasis-Verbundwerkstoffen | |
AU2003286264A1 (en) | Rigid composite structure | |
AUPS038702A0 (en) | Construction products with integrated photovoltaics | |
AU2003251553A8 (en) | Extensible structured controlled vocabularies | |
AU2003277582A1 (en) | Fluoropolymer | |
AU2003235549A8 (en) | Double-layer electrochemical capacitor | |
AU2002952265A0 (en) | Implantable sensor | |
TW560284U (en) | The improvement of the baggage structure | |
PL349542A1 (en) | Novel strain of barm saccharomyces cerevisiae | |
TW510433U (en) | Improved structure for the exit of rolling door | |
AU2003236803A8 (en) | Conversion layer for bases made of zinc or zinc alloys | |
AU2003289294A1 (en) | Solid electrolytic capacitor | |
TW554702U (en) | Structure of wardrobe | |
AU2003222004A1 (en) | Methods of diagnosing the presence of trail | |
AU2003294947A8 (en) | Method for the validated construction of arrays | |
AU2003242167A1 (en) | The telephone with outer covering layer of aluminium alloy | |
TW576198U (en) | Structure of cane chair |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |